Metabolic science, examined with clarity.
Exploring behavioral consistency and the GLP-1 lived experience through a lens of intellectual restraint.
Fatty Liver Disease Burden in India: What National Survey Data Reveals About a Hidden Metabolic Crisis
India’s fatty liver disease burden affects an estimated 250-300 million adults — yet most remain…
Same Weight Gain, Different Metabolic Risk
The same 4.5kg gain cut insulin sensitivity 38% in South Asian men but just 7%…
Strength Training for GLP-1 Users: A Simple Muscle-Preservation Guide
GLP-1 weight loss works best with a muscle-preservation plan. Start here: a simple, practical guide…
The Weight Loss Trio: Understanding Muscle Loss, Appetite, and Nausea on GLP-1s
Understand why GLP-1 medications cause muscle loss, appetite suppression, and nausea, and how to manage…
GLP-1 Agonists and Sleep Disorders: How the Treatment Protocol Changed
OSA is the most clinically well-studied sleep disorder in the GLP-1 space and the one…
GLP-1 and Fatty Liver Disease: What the Trial Data Keeps Showing Beyond Weight Loss
GLP-1 agonists improve fatty liver through direct hepatic mechanisms, not just weight loss. What the…
GLP-1 Benefits Beyond Weight Loss: Evidence Review
GLP-1 agonists cut cardiovascular events, protect kidneys, and reverse liver disease. An evidence-graded review of…
Staying Hydrated on GLP-1 Medication This Summer
GLP-1 medications suppress thirst signals alongside hunger. Learn why dehydration sneaks up on GLP-1 users,…
GLP-1 Drugs and PCOS Fertility: Can They Restore Ovulation?
Women with PCOS are regaining fertility on GLP-1 medications. Here is the mechanism, and the…
GLP-1 Success: A Data-Driven Framework for Better Results
The scale misses what matters on GLP-1 therapy. Track 4 key signals to see what…
Saving Your Skin: What GLP-1 Users Need to Know Before Summer
Ozempic Face is real. GLP-1s also suppress thirst and thin the skin barrier. Here is…
Precision Dosing: Can GLP-1 Microdoses Solve Muscle Loss and Inflammation?
Standard GLP-1 dose escalation may be accelerating muscle loss. Here’s what early microdosing research shows…
Does GLP-1 Cause Hair Loss? What the Data Shows
Hair loss on semaglutide gets blamed on the drug. The mechanism points elsewhere. What telogen…
The Relapse Prediction Model: Why Some GLP-1 Users Keep the Weight Off
Most GLP-1 users regain two-thirds of lost weight within a year of stopping.
But not everyone….
Why GLP-1s Work Even When You Can’t Stop Thinking About Food
Weight regain after stopping GLP-1 medications is not a willpower failure.
It is biology reclaiming a…
Food Noise Isn’t Cravings. Here’s the Brain Scan Difference
Is food noise a reward signal or a cognitive loop? Explore the brain scan differences…
DMN: The Rumination Network and Maladaptive Prospection
How the default mode network drives maladaptive prospection, chronic rumination, and its metabolic cost. Evidence-based…
When You Stop GLP-1s, Your Brain Notices First
GLP-1 cessation affects six brain systems simultaneously. New data shows the DMN and reward circuits…
Cognitive Energetics & GLP-1: The Hidden Reason Behavior Change Feels Hard
Discover how cognitive energetics explains why behavior change feels hard—even on GLP-1. Learn the neuroscience…
The Five Movement Signals Your Metabolism Still Understands
Your metabolism does not recognize gym memberships or workout streaks. It responds to five ancient…
Join the Field Notes
Coming Soon: Join the waitlist for our official launch.
One core insight per issue. A calm, research-aware approach to metabolic science and behavioral adaptation delivered weekly.
The form has been submitted successfully!
There has been some error while submitting the form. Please verify all form fields again.